A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody-Reference-Cited by-同舟云学术

A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody

Published:2015-06-01 Issue:6 Volume:10 Page:e0128381
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chain Benny,Arnold Jack,Akthar Samia,Brandt Michael,Davis David,Noursadeghi Mahdad,Lapp Thabo,Ji Changhua,Sankuratri Surya,Zhang Yanjing,Govada Lata,Saridakis Emmanuel,Chayen Naomi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Chemokines and chemokine receptors: positioning cells for host defense and immunity;JW Griffith;Annu Rev Immunol,2014

2. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer;P Weitzenfeld;Cancer Lett

3. Chemokine receptor CCR5: from AIDS to atherosclerosis;KL Jones;Br J Pharmacol,2011

4. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene;M Samson;Nature,1996

5. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection;R Liu;Cell,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C₆Mab-19 with the High Binding Affinity in Flow Cytometry;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-08-01

2. Identification of the Binding Epitope of an Anti-Mouse CCR6 Monoclonal Antibody (C6Mab-13) Using 1× Alanine Scanning;Antibodies;2023-04-28

3. Monoclonal CCR5 Antibody: A Promising Therapy for HIV;Current HIV Research;2023-03

4. Epitope Mapping of an Anti-Mouse CXCR6 Monoclonal Antibody (Cx₆Mab-1) Using the 2 × Alanine Scanning Method;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-10-01

5. Cx₆Mab-1: A Novel Anti-Mouse CXCR6 Monoclonal Antibody Established by N-Terminal Peptide Immunization;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2022-06-01